CytomX Therapeutics, Inc. (CTMX)
2.86
+0.17
(+6.32%)
USD |
NASDAQ |
Sep 16, 11:56
CytomX Therapeutics Market Cap : 623.19M for Sept. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 15, 2026 | 586.15M |
| September 14, 2026 | 697.28M |
| September 11, 2026 | 716.89M |
| September 10, 2026 | 729.96M |
| September 09, 2026 | 771.36M |
| September 08, 2026 | 795.33M |
| September 04, 2026 | 808.41M |
| September 03, 2026 | 801.87M |
| September 02, 2026 | 810.59M |
| September 01, 2026 | 799.69M |
| August 31, 2026 | 732.14M |
| August 28, 2026 | 699.46M |
| August 27, 2026 | 745.22M |
| August 26, 2026 | 723.43M |
| August 25, 2026 | 734.32M |
| August 24, 2026 | 716.89M |
| August 21, 2026 | 714.71M |
| August 20, 2026 | 716.89M |
| August 19, 2026 | 777.90M |
| August 18, 2026 | 738.68M |
| August 17, 2026 | 751.75M |
| August 14, 2026 | 732.14M |
| August 13, 2026 | 729.96M |
| August 12, 2026 | 760.47M |
| August 11, 2026 | 751.75M |
| Date | Value |
|---|---|
| August 10, 2026 | 749.57M |
| August 07, 2026 | 753.93M |
| August 06, 2026 | 734.32M |
| August 05, 2026 | 729.96M |
| August 04, 2026 | 723.43M |
| August 03, 2026 | 690.09M |
| July 31, 2026 | 674.85M |
| July 30, 2026 | 714.04M |
| July 29, 2026 | 690.09M |
| July 28, 2026 | 700.97M |
| July 27, 2026 | 707.51M |
| July 24, 2026 | 705.33M |
| July 23, 2026 | 724.92M |
| July 22, 2026 | 724.92M |
| July 21, 2026 | 744.51M |
| July 20, 2026 | 766.28M |
| July 17, 2026 | 788.05M |
| July 16, 2026 | 797.85M |
| July 15, 2026 | 801.11M |
| July 14, 2026 | 796.76M |
| July 13, 2026 | 805.47M |
| July 10, 2026 | 818.53M |
| July 09, 2026 | 860.98M |
| July 08, 2026 | 833.77M |
| July 07, 2026 | 835.94M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 80.37B |
| ACADIA Pharmaceuticals, Inc. | 4.715B |
| Alnylam Pharmaceuticals, Inc. | 32.12B |
| Anika Therapeutics, Inc. | 280.37M |
| Savara, Inc. | 1.082B |
Market Cap Related Metrics
| PS Ratio | 28.57 |
| Price to Book Value | 2.063 |
| Price | 2.86 |
| Earnings Yield | -15.98% |